Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0000950170-25-008451

President and CEO sold 375,000 shares at an average $4.70 ($1,762,500)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Sanjiv President and CEO 2025-01-21 Sale 10b5-1 −125,000 $4.52 $565,000 449,548 I
Patel Sanjiv President and CEO 2025-01-22 Sale 10b5-1 −125,000 $4.80 $600,000 324,548 I
Patel Sanjiv President and CEO 2025-01-23 Sale 10b5-1 −125,000 $4.78 $597,500 199,548 I
Open-market sales · 375,000 sh · avg $4.70 · $1,762,500
Loading xslF345X05/ownership.xml…